| 000 | 01596nam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 090423s2008 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng. | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc. | ||
| 099 | _aCai01.11.23.M.Sc.2008.Ma.R. | ||
| 100 | 0 | _aMai Mohamed Osama Elarini | |
| 245 | 1 | 0 |
_aRecent trends in the management of hormone - refractory prostate cancer / _cMai Mohamed Osama Elarini ; Supervised Emad Mahmoud Hamada , Ezzat Safwat Saad , Wael Abdelgawad |
| 246 | 1 | 5 | _aالطرق الجديدة في علاج اورام البروستاتا الغير مستجيبة للعلاج الهرموني |
| 260 |
_aCairo : _bMai Mohamed Osama Elarini , _c2008 |
||
| 300 |
_a101 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology Clinical | ||
| 520 | _aProstate cancer is a sigificant health concern for men world wide. Adenocarcinoma of the prostate is currently the most frequent malignancy in men and is responsible for the second greatest number of cancer-related deaths after lung cancer approxirr ately 1 man in 5 will be diagnosed with prostate cancer during his lifetime | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHRPC | |
| 653 | 4 | _aRecent trends | |
| 653 | 4 | _aRefractory prostate cancer | |
| 700 | 0 |
_aEmad Mahmoud Hamada , _eSupervisor |
|
| 700 | 0 |
_aEzzat Safwat Saad , _eSupervisor |
|
| 700 | 0 |
_aWael Abdelgawad , _eSupervisor |
|
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c16214 _d16214 |
||